文献速递睡眠呼吸障碍间质性肺疾病

持续气道正压通气不改善阻塞性睡眠呼吸暂停合并非酒精性脂肪性肝病

Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

本研究为随机临床试验,纳入120例合并非酒精性脂肪性肝病(NAFLD)的阻塞性睡眠呼吸暂停(OSA)患者,比较自动调节CPAP与亚治疗压力CPAP治疗6个月对NAFLD活动度的影响。结果显示两组在主要终点肝内甘油三酯变化及关键次要终点上均无显著差异,而6个月内体重变化与肝内甘油三酯和CAP变化相关。

要点

  • CPAP治疗6个月未显著改善OSA合并NAFLD患者的肝脂肪变或纤维化。
  • 肝脂肪变指标与OSA严重程度指标存在显著但弱的相关性。
  • 体重变化与肝内甘油三酯及CAP变化显著相关,生活方式减重值得进一步研究。

核心结论

  • 尽管肝脂肪变与OSA严重程度标志物显著相关,单用CPAP未改善肝脂肪变和纤维化。
  • 通过生活方式减重的作用值得进一步研究。

研究设计与样本

  • 随机临床试验,纳入NAFLD合并OSA患者,OSA定义为呼吸事件指数≥5/h(经验证的3级Embletta设备诊断)。
  • 共120例患者随机等分为两组:自动调节CPAP组(4-20 cm H2O)和亚治疗CPAP组(压力固定于4 cm H2O),治疗6个月。

主要发现

  • CAP与呼吸事件指数相关(r=0.203,P=0.026),与SaO2<90%占总记录时间百分比相关(r=0.265,P=0.003),与氧减指数相关(r=0.214,P=0.019)。
  • 治疗6个月后,两组主要终点和次要终点变化均无显著差异。
  • 回归分析显示6个月内体重变化与肝内甘油三酯和CAP变化相关(P<0.001)。

关键数值与推荐

  • 主要终点为治疗6个月后经质子磁共振波谱测定的肝内甘油三酯变化差异。
  • 关键次要终点包括瞬时弹性成像测定的受控衰减参数(CAP)、肝硬度值及血清细胞角蛋白-18片段的变化。

临床怎么用

  • 对于OSA合并NAFLD患者,不应仅依赖CPAP来改善肝脏脂肪变或纤维化。
  • 应关注体重管理,体重变化与肝脏脂肪变指标相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Obstructive sleep apnea (OSA) is associated with development of nonalcoholic fatty liver disease (NAFLD). The effects of continuous positive airway pressure (CPAP) on NAFLD in patients with concomitant OSA are unknown.Objectives: To investigate the effects of autoadjusting CPAP versus subtherapeutic CPAP treatment over 6 months on NAFLD activities.Methods: Patients with NAFLD and OSA, as defined by respiratory event index ≥5/h diagnosed by a validated level 3 Embletta device, were randomized into group A) autoadjusting CPAP (4-20 cm H2O) or group B) subtherapeutic CPAP (pressure fixed at 4 cm H2O). The primary endpoint was the difference in changes in intrahepatic triglyceride as measured by proton magnetic resonance spectroscopy after 6 months of therapy. Key secondary endpoints included changes in controlled attenuation parameter (CAP) and liver stiffness measurement measured with transient elastography, and serum cytokeratin-18 fragment.Measurements and Main Results: A total of 120 patients were randomized equally into two groups. There were significant correlations between CAP and respiratory event index (r = 0.203, P = 0.026), percentage of total recording time with SaO2 < 90% (r = 0.265, P = 0.003), and oxygen desaturation index (r = 0.214, P = 0.019). After 6 months of treatment, there were no significant differences of changes in primary and secondary endpoints between the two treatment groups. Regression analysis showed that weight change over 6 months correlated with changes in both intrahepatic triglyceride and CAP (P < 0.001).Conclusions: Despite significant correlations between hepatic steatosis and markers of severity of OSA, CPAP alone did not improve hepatic steatosis and fibrosis. However, the additional role of weight reduction through lifestyle modification deserves further investigation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ng SSS, Wong VWS, Wong GLH, et al. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial. Am J Respir Crit Care Med. 2021. PMID: 32926803. doi:10.1164/rccm.202005-1868OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。